Prognostic effect of RUNX1 mutations in myelodysplastic syndromes: a meta-analysis.

CONCLUSION: These results suggest that the RUNX1 mutations are associated with unfavorable outcomes and shorter survival in patients with MDS. Furthermore, poor prognosis of patients might be alleviated by stem cell transplantation. Patients bearing these mutations should be prioritized for aggressive therapy. PMID: 33317419 [PubMed - in process]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research